p.novak
TL2 · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 13 September 2025 · last posted 5d
96 posts, newest first. Showing up to 150.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #95 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 0 likes Adding the measurement that post #94 says would settle it. The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #84 · Access › Insurance & coverage · 19 Jul 2026 · 9 likes Post #81 is the version of this I will quote in future. One addition. The question underneath Prior authorisation is usually "how would I tell?" rather than "what is…
-
What a certificate commits its issuer to Replied, post #42 · Analytics › COA interpretation · 16 Jul 2026 · 6 likes Adding the measurement that post #41 says would settle it. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #47 · Practice › Interactions · 15 Jul 2026 · 24 likes Confirming post #46 from a second method, which matters more than confirming it from a second person. Since Antibiotics keeps coming up, it should probably be a…
-
What a good consultation looks like from the other side Replied, post #59 · Clinical › Prescriber conversations · 14 Jul 2026 · 1 like On post #57 — agreed on the reasoning, with one qualification. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
-
Insurance and replacement policies, compared Replied, post #69 · Sourcing › Logistics · 7 Jul 2026 · 31 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. I would be interested in a counterexample if anyone has…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #89 · Practice › Administration · 3 Jul 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #10 · Compounds › Repair & healing peptides · 2 Jul 2026 · 14 likes Marking my place. If it changes for me I will come back and say so.
-
Official shortage notices and what they authorise Replied, post #117 · Access › Shortages · 20 Jun 2026 · 0 likes The thing about official shortage notices that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #31 · Evidence › Meta-analyses · 15 Jun 2026 · 19 likes Answering the question post #29 raises rather than the one it answers. The forest plot ordered by the variable you think explains the spread is more informative than…
-
Books and papers worth reading that are not about this at all — one year on Replied, post #8 · Lounge › Off topic · 14 Jun 2026 · 19 likes Loosely related and not worth its own topic: the vocabulary here has leaked into how I read everything. I now notice when a press release gives a relative figure and no…
-
Private prescribing in the UK: what is actually involved Replied, post #38 · Regional › UK & Ireland · 14 Jun 2026 · 3 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Started this topic · Analytics › Impurities & related substances · 13 Jun 2026 · 1 like Named, unnamed and unspecified impurities as regulatory categories — the long version — setting out what I have, and where I think it stops being reliable. Two reports…
-
Racemisation and why it is invisible to a mass measurement Replied, post #31 · Analytics › Impurities & related substances · 10 Jun 2026 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #48 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 7 likes Where I part company with post #44, and it is a narrow parting. An observation about peak-to-trough ratio that I cannot explain and am posting anyway, on the principle…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #33 · Clinical › Special populations · 31 May 2026 · 20 likes Thank you — that answers what I came here to find out.
-
Tracking intake honestly when appetite is absent Replied, post #34 · Nutrition & Training › Protein & intake · 23 May 2026 · 9 likes Post #33 is right about the mechanism and I think understates the practical bit. The mechanism is not mysterious. Substantial energy restriction with inadequate protein…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #27 · Analytics › Home & field testing · 21 May 2026 · 0 likes The tare problem is the catch with weighing: vial-to-vial glass mass varies, so the useful measurement is the spread across a consignment rather than an absolute figure.
-
The best-written scientific paper you have read Replied, post #49 · Lounge › Off topic · 16 May 2026 · 1 like That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Spreadsheets: an appreciation — what changed since Replied, post #43 · Lounge › Off topic · 15 May 2026 · 1 like One more thing on Spreadsheets that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
An 18-month record including the parts that went badly Replied, post #13 · Outcomes › Progress reports · 10 May 2026 · 16 likes Adding a data point of agreement rather than a data point.
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #3 · Analytics › COA interpretation · 27 Apr 2026 · 18 likes My position on field-by-field walk through a certificate is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Temperature indicator cards: worth asking for? Replied, post #6 · Sourcing › Logistics · 23 Apr 2026 · 5 likes Answering the question post #4 raises rather than the one it answers. Where I would push back on the temperature indicator cards consensus is the confidence, not the…
-
[2026 update] What a purity-only report leaves out Replied, post #98 · Sourcing › Independent verification · 21 Apr 2026 · 5 likes The confident answers on purity-only and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #45 · Practice › Interactions · 13 Apr 2026 · 7 likes Understood, and I withdraw the assumption I opened with.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #12 · Devices › Syringes & needles · 10 Apr 2026 · 24 likes I read post #10 twice before replying, because I had assumed the opposite. Reading the barrel at eye level matters more than any equipment choice. Parallax at a shallow…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #3 · Devices › Syringes & needles · 1 Apr 2026 · 1 like Adding thanks rather than a view. I do not have a view worth the space.
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #54 · Data & Tools › Calculators · 27 Mar 2026 · 30 likes Two things can be true about titration planner refuses at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #20 · Compounds › Secretagogues & GH axis · 17 Mar 2026 · 12 likes Picking up post #19: that is the part I would want checked first. The question underneath Evidence quality is usually "how would I tell?" rather than "what is true?",…
-
Measurement error in a self-reported exposure Replied, post #64 · Evidence › Study critique · 25 Feb 2026 · 0 likes Worth separating two things that post #60 runs together. The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #120 · Practice › Dosing & titration · 21 Feb 2026 · 5 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 19 Feb 2026 · 8 likes The documentation on nausea profile of amylin analogues is better than this thread and I say that as someone who has posted in the thread.
-
Research-use-only labelling: what it means and what it does not Replied, post #102 · Sourcing › Regulatory · 13 Feb 2026 · 0 likes Research-use-only labelling has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
A single out-of-range value on an otherwise normal panel Replied, post #13 · Clinical › Bloodwork · 12 Feb 2026 · 9 likes I read post #9 twice before replying, because I had assumed the opposite. Two things can be true about single out-of-range value at once: the mechanism is plausible and…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #4 · Outcomes › Body composition · 29 Dec 2025 · 10 likes Where I part company with post #2, and it is a narrow parting. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #37 · Compounds › Other compounds · 23 Dec 2025 · 0 likes On post #36 — agreed on the reasoning, with one qualification. I think the AOD-9604 question is answerable and has not been answered, which is a more optimistic…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #2 · Sourcing › Vendor reports · 17 Dec 2025 · 5 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Getting a referral rather than a refusal Replied, post #4 · Clinical › Prescriber conversations · 6 Dec 2025 · 0 likes Adding the measurement that post #3 says would settle it. Before the thread moves on from getting a referral — what is the sample size behind the claim? I am not being…
-
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common… Replied, post #7 · Practice › Storage & stability · 2 Dec 2025 · 16 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Managing an unplanned gap in supply — what changed since Replied, post #118 · Access › Shortages · 16 Nov 2025 · 0 likes Worth separating two things that post #117 runs together. Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #48 · Compounds › Tirzepatide · 12 Nov 2025 · 2 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
-
Reading SURMOUNT-1 without the press release Replied, post #60 · Compounds › Tirzepatide · 9 Nov 2025 · 0 likes Taking post #57 at face value and following it one step further. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
-
New subcategory: rationale and scope Replied, post #116 · Meta › Announcements · 25 Oct 2025 · 30 likes Good question, well framed, and I would like to see it answered properly.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #20 · Start Here › How to Ask · 23 Oct 2025 · 2 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Payment mechanics and the recovery options that do not exist Replied, post #55 · Sourcing › Payments · 21 Oct 2025 · 10 likes This follows post #54 rather than contradicting it. No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #47 · Compounds › Tirzepatide · 21 Oct 2025 · 14 likes The arithmetic in post #44 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on SURMOUNT-4 is that it depends on…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #13 · Practice › Storage & stability · 20 Oct 2025 · 22 likes My position on Storing lyophilised material long term is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Sleep tracking data and its considerable limitations Replied, post #34 · Wellbeing › Sleep · 19 Oct 2025 · 18 likes Answering the question post #32 raises rather than the one it answers. Sleep quality versus quantity: some people report changes to sleep duration; others report…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #115 · Practice › Administration · 17 Oct 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Reading an interaction checker output critically Replied, post #16 · Practice › Interactions · 5 Oct 2025 · 1 like Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.
-
High-resolution MS on aggregates and what it can see Replied, post #66 · Analytics › Mass spectrometry · 12 Sep 2025 · 18 likes Posting my high-resolution numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Payment method and the leverage it gives you, ranked Replied, post #3 · Sourcing › Payments · 12 Sep 2025 · 6 likes Counterpoint on payment method, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #80 · Data & Tools › Datasets · 9 Sep 2025 · 6 likes Post #76 describes the usual case. This is about the unusual one. Answering the Aggregated purity results across four question as asked, then the question I think is…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #3 · Research Methods › N-of-1 designs · 1 Sep 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Stopping rules: decide in advance when you will stop measuring (after a defined…
-
Temperature loggers worth the money Replied, post #24 · Devices › Cold chain · 30 Aug 2025 · 0 likes Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They are the only thing that turns an argument about transit into a record.…
-
Specification in the result column: why that is a meaningful error Replied, post #36 · Analytics › COA interpretation · 27 Aug 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #31 · Evidence › Journal club · 24 Aug 2025 · 25 likes Posting my indirect comparison numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #58 · Compounds › Retatrutide · 21 Aug 2025 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
When to stop reading forums, including this one Replied, post #14 · Wellbeing › Mental health · 12 Aug 2025 · 0 likes If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum cannot help and waiting costs time.
-
A ten-fold dose error caught before injection — one year on Replied, post #126 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes Narrowing post #125, because the general version has more than one answer. Adding a small correction to the ten-fold dose error caught summary above rather than a…
-
How to research a compound with no human data without deceiving yourself Replied, post #93 · Compounds › Other compounds · 3 Aug 2025 · 7 likes Post #91 put the caveat in the right place and I want to underline it. For any compound without a widely available reference standard, retention-time comparisons across…
-
How to research a compound with no human data without deceiving yourself Replied, post #78 · Compounds › Other compounds · 3 Aug 2025 · 4 likes Post #77 answers the question as asked. The question underneath it is different. Worth separating research a compound as a question about the compound from research a…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #13 · Practice › Reconstitution · 29 Jul 2025 · 5 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #28 · Practice › Reconstitution · 20 Jul 2025 · 28 likes Noted, and thank you for writing it out rather than summarising it.
-
A field-by-field walk through a certificate of analysis Replied, post #62 · Analytics › COA interpretation · 16 Jul 2025 · 27 likes Post #60 and I disagree about the size of the effect, not about the direction. Peptide content and chromatographic purity are separate determinations and a certificate…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #81 · Wellbeing › Mental health · 2 Jul 2025 · 0 likes Second this, and I would have said it less carefully.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #130 · Clinical › Comorbidities · 30 Jun 2025 · 13 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #146 · Practice › Reconstitution · 26 Jun 2025 · 11 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Substitution between formats during a shortage Replied, post #12 · Access › Shortages · 21 Jun 2025 · 2 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out. I would call that likely rather than…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #136 · Compounds › Cagrilintide & amylin analogues · 18 Jun 2025 · 21 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #14 · Sourcing › Payments · 11 Jun 2025 · 1 like Escrow services: some third-party services hold payment until the buyer confirms receipt. They add cost but reduce risk if the supplier is unknown.
-
Coming back to: When "no data" is the complete and final answer Replied, post #4 · Compounds › Other compounds · 2 Jun 2025 · 12 likes Narrowing the opening post, because the general version has more than one answer. Peptides with cyclic or disulphide-constrained structures behave differently on a…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #41 · Regional › UK & Ireland · 29 May 2025 · 2 likes Where I part company with post #39, and it is a narrow parting. Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so…
-
Antibiotics and a course of something with delayed emptying Replied, post #39 · Practice › Interactions · 11 May 2025 · 3 likes The version of antibiotics that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Adjudicated events and why the definition matters — the long version Replied, post #114 · Evidence › Trials · 23 Apr 2025 · 16 likes I read the earlier replies on Adjudicated events twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
-
Requesting a page: what makes a good request Replied, post #57 · Documentation › Wiki requests · 14 Apr 2025 · 0 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #37 · Practice › Reconstitution · 14 Apr 2025 · 0 likes Narrowing post #35, because the general version has more than one answer. The thing about 10 mg vial reconstituted three that took me longest to accept is that a…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #68 · Wellbeing › Mental health · 30 Mar 2025 · 2 likes I would put moderate confidence on the mainstream reading of anxiety and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #19 · Sourcing › Vendor reports · 24 Mar 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Transit times by route, from a logged dataset — the long version Replied, post #73 · Sourcing › Logistics · 22 Mar 2025 · 3 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
A promotion I argued against, and why I lost Replied, post #108 · Documentation › Doc review · 23 Feb 2025 · 22 likes Post #106 answers the question as asked. The question underneath it is different. The most useful reply I ever got about promotion was a request to state my units. It…
-
Coming back to: Official shortage notices and what they authorise Replied, post #31 · Access › Shortages · 21 Feb 2025 · 0 likes Picking up post #30: that is the part I would want checked first. Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #70 · Compounds › Secretagogues & GH axis · 5 Feb 2025 · 0 likes The most useful single question to ask about any compound in this family is what the published human evidence actually consists of. In several cases the honest answer…
-
Canadian access and provincial variation Replied, post #16 · Regional › North America · 24 Jan 2025 · 8 likes Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use.
-
What changed in 2026, by region Replied, post #23 · Access › International · 15 Dec 2024 · 12 likes Date your answer and name your region. A position that is true in one jurisdiction and stated without either is the commonest source of confusion here.
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #34 · Practice › Side effects · 14 Dec 2024 · 0 likes This follows post #32 rather than contradicting it. A symptom that starts weeks after a dose has been stable is a different observation from one that starts after an…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #12 · Practice › Interactions · 3 Dec 2024 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Research-use-only compounds have no interaction data of any kind, because interaction studies…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #35 · Practice › Side effects · 30 Nov 2024 · 18 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Fixed versus detachable needles: the trade-offs Replied, post #11 · Devices › Syringes & needles · 20 Nov 2024 · 9 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #63 · Clinical › Comorbidities · 19 Oct 2024 · 5 likes Adding the measurement that post #61 says would settle it. The reason Hypertension improvement keeps being re-asked is that the answer is conditional and people quote…
-
Food noise reducing and the disorientation that can follow Replied, post #16 · Wellbeing › Mental health · 3 Oct 2024 · 23 likes Two sentences on food noise and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #49 · Practice › Administration · 23 Sep 2024 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #56 · Clinical › Prescriber conversations · 13 Sep 2024 · 0 likes A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one is a legitimate question.
-
Correlation in a self-tracked dataset: what it can support Replied, post #131 · Research Methods › Statistics · 25 Aug 2024 · 15 likes A request rather than an answer: could whoever has the primary source for correlation post it? I have seen the claim three times this month and each version had lost a…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #16 · Analytics › Method validation · 15 Aug 2024 · 5 likes Thank you — that answers what I came here to find out.
-
How this community labels and discusses unrefereed work Replied, post #92 · Evidence › Preprints · 17 Jul 2024 · 0 likes Picking up post #89: that is the part I would want checked first. Two people in this thread mean different things by community labels and are disagreeing about the…